EAM
ALKS icon

Exome Asset Management’s Alkermes ALKS Stock Holding History

Exome Asset Management’s Portfolio ALKS Stock Details ALKS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.21M Sell
61,336
-22,767
-27% -$889K 1.98% 20
2026
Q1 		$2.97M Buy
+84,103
New +$2.61M 1.54% 25

Other funds holding ALKS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

Exome Asset Management's ALKS Position: Q2 2026 in Review

Exome Asset Management reduced its Alkermes (ALKS) stake by 27% in Q2 2026, selling an estimated $889K and leaving 61,336 shares worth $3.21M. The position accounts for 1.98% of the portfolio, ranked #20.

Exome Asset Management first reported a position in ALKS in Q1 2026 and has held it in 2 quarters since. 425 funds tracked by Wall St. Rank hold ALKS as of Q2 2026.

  • Exome Asset Management held 61,336 shares of Alkermes worth $3.21M as of Q2 2026.
  • Exome Asset Management sold 22,767 Alkermes shares in Q2 2026, an estimated $889K.
  • Alkermes made up 1.98% of Exome Asset Management's portfolio in Q2 2026, its #20 holding.
  • Exome Asset Management first reported a position in Alkermes in Q1 2026 and has held it in 2 quarters since.
  • 425 funds tracked by Wall St. Rank held Alkermes as of Q2 2026.

Based on Exome Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.